Header cover image
  • Investing Ideas
  • /
  • Danish Pharmaceuticals & Biotech High Return On Equity, Low Debt

Danish Pharmaceuticals & Biotech High Return On Equity, Low Debt

Results

1

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Zealand Pharma

Market Cap: DKK 35.2b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

ZEAL

DKK 500.60

7D

8.9%

1Y

-39.5%